Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fenghuang Zhan

Showing results (1-10 of 199) with videos related to

Pageof 20
Sort By:
Cancers|November 25, 2023
Type 2 Cystatins and Their Roles in the Regulation of Human Immune Response and Cancer ProgressionZijun Zhang, Fenghuang Zhan
Current Opinion in Supportive and Palliative Care|July 27, 2010
Bone and paraproteinemiasMaurizio Zangari, Fenghuang Zhan, Guido Tricot
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 30, 2014
[Myeloma cancer stem cells:the new target for multiple myeloma]Lu Gao, Fenghuang Zhan, Jumei Shi
Biomed Research International|May 23, 2015
Drug resistance in hematologic malignancies: induction mechanisms, genetics, and therapeuticsFenghuang Zhan, Maurizio Zangari, Lugui Qiu
Seminars in Hematology|October 29, 2003
Toward the identification of distinct molecular and clinical entities of multiple myeloma using global gene expression profilingFenghuang Zhan, Bart Barlogie, John Shaughnessy
The New England Journal of Medicine|September 7, 2007
Smoldering multiple myelomaH Keshava Prasad, Fenghuang Zhan, John Shaughnessy
Cancer Treatment Reviews|January 10, 2012
Impact of bortezomib on bone health in myeloma: a review of current evidenceMaurizio Zangari, Evangelos Terpos, Fenghuang Zhan, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 18, 2011
Low venous thromboembolic risk with bortezomib in multiple myeloma and potential protective effect with thalidomide/lenalidomide-based therapy: review of data from phase 3 trials and studies of novel combination regimensMaurizio Zangari, Louis Fink, Fenghuang Zhan, et al.
American Journal of Blood Research|March 21, 2012
Progress in myeloma stem cellsRichard Dela Cruz, Guido Tricot, Maurizio Zangari, et al.
Best Practice & Research. Clinical Haematology|July 20, 2005
Gene expression profiling and multiple myelomaJohn Shaughnessy, Fenghuang Zhan, Barthel Barlogie, et al.
Pageof 20

Showing results (1-10 of 199) with videos related to

Sort By:
Pageof 20
Cancers|November 25, 2023
Type 2 Cystatins and Their Roles in the Regulation of Human Immune Response and Cancer ProgressionZijun Zhang, Fenghuang Zhan
Current Opinion in Supportive and Palliative Care|July 27, 2010
Bone and paraproteinemiasMaurizio Zangari, Fenghuang Zhan, Guido Tricot
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|December 30, 2014
[Myeloma cancer stem cells:the new target for multiple myeloma]Lu Gao, Fenghuang Zhan, Jumei Shi
Biomed Research International|May 23, 2015
Drug resistance in hematologic malignancies: induction mechanisms, genetics, and therapeuticsFenghuang Zhan, Maurizio Zangari, Lugui Qiu
Seminars in Hematology|October 29, 2003
Toward the identification of distinct molecular and clinical entities of multiple myeloma using global gene expression profilingFenghuang Zhan, Bart Barlogie, John Shaughnessy
The New England Journal of Medicine|September 7, 2007
Smoldering multiple myelomaH Keshava Prasad, Fenghuang Zhan, John Shaughnessy
Cancer Treatment Reviews|January 10, 2012
Impact of bortezomib on bone health in myeloma: a review of current evidenceMaurizio Zangari, Evangelos Terpos, Fenghuang Zhan, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 18, 2011
Low venous thromboembolic risk with bortezomib in multiple myeloma and potential protective effect with thalidomide/lenalidomide-based therapy: review of data from phase 3 trials and studies of novel combination regimensMaurizio Zangari, Louis Fink, Fenghuang Zhan, et al.
American Journal of Blood Research|March 21, 2012
Progress in myeloma stem cellsRichard Dela Cruz, Guido Tricot, Maurizio Zangari, et al.
Best Practice & Research. Clinical Haematology|July 20, 2005
Gene expression profiling and multiple myelomaJohn Shaughnessy, Fenghuang Zhan, Barthel Barlogie, et al.
Pageof 20